Register to Vote: Rock the Vote, powered by Credo Mobile

HOME

ABOUT US

OUR ISSUES

Federal Budget

Information & Access

Nonprofit Advocacy


PRESS ROOM

ACTION CENTER

PUBLICATIONS

THE WATCHER

OUR BLOGS


SIGN UP

Receive news, updates, and alerts!

DONATE

Help support our work


OTHER SITES

FedSpending.org

RTK NET

NPAction

Working Group on Community Right-to-Know

Citizens for Sensible Safeguards

Open the Government

OMB Watch Logo

"[P]eople acting in a group can accomplish things which no individual acting alone could even hope to bring about." - FDR

Home :  Regulatory Policy :  RegWatch : 
RegWatch:     

News & Analysis | REG•WATCH Blog | Press Room

 R    E    G    •    W    A    T    C    H 


Wednesday, February 14, 2007

Two House Committees Examine Bush Regulatory Amendments

Yesterday, two House subcommittees held back-to-back oversight hearings investigating President Bush's recent amendments to Executive Order 12866 — Regulatory Planning and Review.

The first hearing, held by the House Science and Technology Committee subcommittee on Investigations and Oversight, delved into the specific impacts of the amendments.

  • OMB Watch's own Rick Melberth framed the amendments as the next step in a disturbing trend where the White House has adopted tools to delay regulation.
  • Rep. Brian Baird (D-WA) wondered how the marketplace incentivized certain protections.
  • Witness and former OIRA administrator Sally Katzen criticized the administration for exerting influence over agency guidance documents.
  • And subcommittee Chair Brad Miller (D-NC) chastised the influence of the Presidential appointees who will serve as Regulatory Policy Officers:
If an RPO makes the wrong decision for the wrong reason, we're not going to know about it.

Rep. James Sensenbrenner (R-WI), the ranking member on the subcommittee, exhibited a lack of understanding of the issue at large. He claimed the amendments do not require "additional hurdles to be overcome" and he muddled the separate issues of market failures and cost-benefit analyses. He left abruptly in the middle of the hearing.

The second hearing, held by the House Judiciary Committee subcommittee on Commercial and Administrative Law, focused on action Congress could take. Committee Chair John Conyers (D-MI) and subcommittee Chair Linda Sanchez (D-CA) both asked witnesses what Congress could do. While Columbia University law professor Peter Strauss admitted Congress's options are limited, Curtis Copeland from the Congressional Research Service pointed out that Congress may declare that Executive Orders not hold any legal sway. Rep. William Delahunt (D-MA) is ready to "wage war" on the "institutional combat" against the legislative branch.

Read more from The Pump Handle here.



Posted by Matt Madia, 12:52:21 PM



Tuesday, February 13, 2007

Watch the hearing live!
OMBW's Rick Melberth has already given his testimony, and now Subcommittee Chair Brad Miller is questioning the panel. Tune in now here. Katzen on OMB's guidance document provisions: "The idea that this is business as usual...couldn't be further from the truth."

Posted by Genevieve Smith, 01:18:51 PM



Friday, February 09, 2007

House Oversight on Bush's E.O. Amendments

On Feb. 13, the House will hold a joint subcommittee hearing titled, "Amending Executive Order 12866: Good Governance or Regulatory Usurpation?" The hearing will include testimony by former OIRA administrator Sally Katzen, Georgetown law professor David Vladeck, and OMB Watch's own Rick Melberth.

On Jan. 18, President Bush issued a slew of amendments to Executive Order 12866 — Regulatory Planning and Review. The amendments vary in their specific impact, but share the goal of slowing the regulatory process. On Jan. 30, The New York Times published a front page story on the amendments, pushing the issue into the national spotlight. Now, the House Science and Technology Committee Subcommittee on Investigations and Oversight and the House Judiciary Committee Subcommittee on Commercial and Administrative Law (say that three times fast) will hold a joint hearing to investigate.

It is heartening to see Congress exercise its oversight power. Bush's decision to amend the regulatory process undermines our nation's public health and safety protections. Furthermore, it shifts certain Congressional powers into the White House, and shows Mr. Bush's contempt for the people's branch of government. Let's hope the White House is paying attention this Tuesday.



Posted by Matt Madia, 09:35:19 AM



Wednesday, February 07, 2007

Waxman's Time to Shine
The New York Times had a great write-up yesterday on House Government Reform Committee Chairman Henry Waxman (D-CA). Over the years when Waxman served as minority ranking member for the committee, we've watched him take both industry and agencies to task over everything from misleading drug advertisements to manipulation of science. Let's hope he brings that same underdog spirit to his new post. Already he's held hearings on waste, fraud and abuse in Iraq contacting and on political interference in government climate science, and more oversight hearings are planned for the coming months.

Read OMBW's latest issued of the Watcher for more on congressional oversight in the new Congress.

Posted by Genevieve Smith, 06:27:29 PM



Latest Watcher

Be sure to check out the latest issue of our biweekly newsletter, The Watcher. Reg policy articles this time:

Media, Congress Begin to Examine Bush's Executive Order on Regulatory Process

Congress Steps Up Oversight of Executive Branch







Latest Entries by Theme

All Themes

Enforcement

About This Blog

Rollbacks

Safety

Industry Influence

Cost-Benefit Analysis

In Congress

Publications

Consumer Issues

Environment

Public Health

In the Courts

Oversight

In the White House

Most Recent Entries for RegWatch

Senate Moves Bill to Renew Federal Improvement Panel

After Preemption Row, Roof Strength Rule Delayed

Consumers Left in the Dark on Food Safety

Regulatory Attacks on Medicaid Halted

OMB Shutting Out EPA on CO2 Regulation

Bush Regulatory Gatekeepers on House Chopping Block

Lobbyists Opposing FDA Changes

It All Depends on Who You Ask

For Workplace Injuries, Underreporting is under Fire

Tomato Toll in the Thousands, CDC Says

Archived Entries for Oversight

June

May

April

March

February

January

November, 2007

October, 2007

September, 2007

August, 2007

July, 2007

May, 2007

April, 2007

March, 2007

February, 2007

January, 2007

November, 2006

September, 2006

July, 2006

June, 2006

April, 2006

February, 2006

January, 2006

October, 2005

September, 2005

July, 2005

March, 2005

February, 2005

January, 2005

December, 2004

November, 2004

October, 2004